[1]
K. Kangwanyotsak and S. . Tongyoo, “Composite adverse events compared early versus conventional cessation of hydrocortisone in patients with septic shock: Randomized-controlled trial (The CESSHYDRO study): Cessation of hydrocortisone in septic shock patient”, Clin Crit Care, vol. 32, no. 1, p. e240003, Mar. 2024.